Skip to main content
News Directory 3
  • Home
  • Business
  • Entertainment
  • Health
  • News
  • Sports
  • Tech
  • World
Menu
  • Home
  • Business
  • Entertainment
  • Health
  • News
  • Sports
  • Tech
  • World
CMS: Rethinking Competitive Bidding Models

CMS: Rethinking Competitive Bidding Models

September 12, 2025 Victoria Sterling Business

CMS Competitive Bidding ​for DME: A Deep Dive

This‌ analysis examines⁤ the Centers for Medicare & Medicaid Services (CMS) competitive bidding ⁣system for ⁢Durable Medical‌ Equipment​ (DME),its history,current issues,and potential future.

What: CMS is expanding its ⁢competitive bidding ⁢program for DME too include urology, tracheostomy, and ostomy ⁣supplies, building on a system ⁤initially⁣ implemented in 2011. This system aims to lower costs for Medicare by awarding ⁤contracts to DME suppliers based on bids. Tho, the current system and proposed expansion are facing criticism for potentially compromising patient care and access.

Where: The program impacts beneficiaries ⁢nationwide who rely on DME covered by Medicare. The bidding process is managed centrally by CMS, with contracts awarded to suppliers operating in⁤ designated Competitive Bid Areas (CBAs).

When:

* 2011: CMS implemented the⁤ current competitive bidding system, replacing a failed fixed-fee schedule.
* 2021: Round 2021 of⁢ competitive ‌bidding failed to meet savings⁤ goals,leading to⁣ a two-year gap period ‌where CMS reverted to the fee schedule.
* 2025 (proposed): CMS plans to relaunch the ‌program with changes, expanding it to ⁤include urology, tracheostomy, and ostomy supplies.

Why it Matters: The DME market ‌is crucial for patients needing ​medical equipment ‌to maintain independence and avoid costly institutional care. A flawed bidding⁣ system can lead to:
* Reduced Quality of Care: Bidding incentivizes lower costs,‍ potentially resulting in suppliers ⁤offering lower-quality equipment.
* Access issues: ‍ Supplier attrition (companies dropping out) can leave beneficiaries with ⁣limited or⁤ no access to⁣ necessary supplies.
* Financial Strain: while aiming for savings, the system can create⁣ instability in the DME market, potentially impacting supplier viability.
* Inefficient Spending: ⁤ Past failures⁤ demonstrate the system doesn’t consistently achieve its intended cost savings.

Ancient Context & System Flaws:

The⁤ current system arose from the failure of a fixed-fee schedule ‌in compensating ‌DME suppliers. The General Accounting Office (GAO) and the Inspector General of⁢ the Department of Health and Human Services‌ criticized the ⁤fixed-fee approach as wasteful and ‍illogical. CMS then adopted a competitive bidding system, but it contained a ⁣unique and problematic feature:

* Median-Based Pricing: CMS sets the winning bid equal to the median price of all winning ​bidders. This ⁣is a “never before seen” approach that creates adverse incentives. It doesn’t necessarily reflect ⁣the true cost of providing quality DME and can drive‍ down prices to unsustainable levels.

Data on Past Bidding Rounds:

Round Year Areas Affected Supplier Attrition Savings Achieved? Outcome
Round 1 2013 9 CBAs Significant Yes mixed results, some access concerns
Round 2 2016 30 CBAs high Yes Increased access gaps, supplier complaints
2021 2021 Nationwide Very High No Gap ⁢period, reversion to fee ‍schedule

Source: compiled from information in the provided text and publicly available CMS data.

Current Concerns & Proposed Changes:

CMS is attempting to address the flaws of the⁢ previous system in the relaunch.Though, concerns remain, ⁣especially regarding the‌ expansion to⁢ new supply​ categories.The proposed rule changes are being scrutinized by industry stakeholders ⁢(like VGM) who highlight potential challenges.

What’s Next:

* Continued Stakeholder Feedback: CMS is accepting⁢ comments on the proposed rule, allowing for input from suppliers, patient advocacy groups, and othre interested parties.
* Program Relaunch (2025): ⁢ CMS intends⁢ to relaunch the competitive bidding program, incorporating ‍changes based⁤ on feedback.
* Monitoring &⁤ Evaluation: Close monitoring of the program’s impact on patient access,‌ quality of care, and cost savings will be crucial.⁢ Further adjustments may⁣ be necessary.
* Potential Legislative Action: If ‍the program continues to demonstrate significant flaws, legislative intervention may be considered to reform the DME payment system.


Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Related

cms, competitive bidding, DME, durable medical equipment, hhs, ostomy supplies, REGULATIONS, tracheostomy supplies, urology supplies

Search:

News Directory 3

ByoDirectory is a comprehensive directory of businesses and services across the United States. Find what you need, when you need it.

Quick Links

  • Disclaimer
  • Terms and Conditions
  • About Us
  • Advertising Policy
  • Contact Us
  • Cookie Policy
  • Editorial Guidelines
  • Privacy Policy

Browse by State

  • Alabama
  • Alaska
  • Arizona
  • Arkansas
  • California
  • Colorado

Connect With Us

© 2026 News Directory 3. All rights reserved.

Privacy Policy Terms of Service